Novel therapeutic uses of glucan
AssigneeNovogen Research Party, Ltd.
InventorGraham Edmund Kelly
Life of this patent
Estimating the term…
Loading patent…
AssigneeNovogen Research Party, Ltd.
InventorGraham Edmund Kelly
Estimating the term…
A process for the production of β-(1,3)(1,6) glucan from a glucan containing cellular source is described, together with compositions and uses/methods of treatment involving glucan. The process of the invention comprises the steps of: (a) extracting glucan containing cells with alkali and heat, in order to remove alkali soluble components; (b) acid extracting the cells of step (a) with an acid and heat to form a suspension; (c) extracting the suspension obtained of step (b) or recovered hydrolyzed cells with an organic solvent which is non-miscible with water and which has a density greater than that of water separating the resultant aqueous phase, solvent containing phase and interface so that substantially only the aqueous phase comprising β-(1,3)(1,6) glucan particulate material remains; wherein the extraction with said organic solvent provides separation of glucan subgroups comprising branched β-(1,3)(1,6)-glucan, and essentially unbranched β-(1,3) glucan which is associated with residual non-glucan contaminents; and (d) drying the glucan material from step (c) to give microparticulate glucan.
A process for production of β-(1,3)(1,6)-glucan from a glucan containing cellular source which comprises the steps of:
A composition which consists essentially of branched β(1,3)(1,6)-glucan and which is essentially free or unbranched β(1,3) glucan, optionally in association with one or more pharmaceutically acceptable carriers or excipients.
Use of glucan for the manufacture of a medicament for the treatment of skin ulceration or bone fracture or the enhancement of fixation of implanted orthopaedic devices, or for the prevention/treatment of ultraviolet light induced skin damage.
Use of glucan for the treatment of skin ulceration or bone fracture or the enhancement of fixation of implanted orthopaedic devices, or for the prevention/treatment of ultraviolet light induced skin damage.
A method for the treatment of skin ulceration or bone fracture or the enhancement of fixation of implanted orthopaedic devices, or for the prevention/treatment of ultraviolet light induced skin damage which comprises administering glucan to a subject, optionally in association with one or more pharmaceutically, veterinarily or agriculturally acceptable carrier or excipient.
An agent for the treatment of skin ulceration or bone fracture or the enhancement of fixation of implanted orthopaedic devices, or for the prevention/treatment of ultraviolet light induced skin damage which comprises glucan optionally in association with one or more pharmaceutically acceptable carriers or excipients.
Dependencies are inferred from the claim text.